# Breakout Labs A grant program launched in 2012 under the [[Thiel Foundation]] umbrella, providing early-stage funding to hard science and deep technology startups whose research is too scientifically risky for traditional venture capital but too commercially oriented for academic grants. The initial batch funded 12 startups with a total of $4.5M in revolving grants. ## The Investment Architecture Position Breakout Labs occupies a specific niche in the Thiel investment architecture — the **pre-seed science layer**. The full pipeline: | Layer | Vehicle | Function | |-------|---------|----------| | Talent | [[Thiel Fellowship]] | Identifies and recruits young founders | | Science | **Breakout Labs** | Funds technically risky early-stage research | | Venture | [[Founders Fund]] / [[Mithril Capital]] | Series A/B/C for proven companies | | Government | [[In-Q-Tel]] / DOD contracts | Provides revenue and scale for mature companies | | Policy | [[Hoover Institution]] | Generates intellectual frameworks justifying investment thesis | Companies that prove their science through Breakout Labs grants can graduate into the Founders Fund portfolio for subsequent funding rounds. The grant structure (not equity-based initially, converting to equity-like returns through a revenue-participation agreement) allows Breakout Labs to fund projects that would be too speculative even for early-stage VC. This is pipeline logic applied to the **technology layer** of [[the Thiel network]] — parallel to the Thiel Fellowship (which pipelines talent) and Hoover (which pipelines ideas). ## Funding Model Breakout Labs uses a "revolving fund" structure: grants of $50K–$350K with a revenue-participation agreement that returns capital to the fund if the company succeeds. This creates a self-sustaining mechanism — successful companies replenish the pool for the next cohort. The model was designed as an alternative to both traditional grants (which have no return mechanism) and VC (which requires equity stakes that scientists resist at the earliest stages). ## Focus Areas Breakout Labs portfolio companies have clustered in: - **Advanced materials** — novel manufacturing processes, metamaterials - **Energy** — fusion, advanced nuclear, grid-scale storage - **Biotech** — synthetic biology, longevity research, diagnostics - **Computation** — quantum computing, neuromorphic chips, novel architectures Each of these domains has significant defense-technology overlap. ## Defense Tech Relevance While Breakout Labs is not explicitly defense-focused, hard science startups in advanced materials, energy, biotech, and computation overlap heavily with defense applications. The pipeline is: Breakout Labs proves the science → Founders Fund provides growth capital → the company pursues dual-use applications → DOD contracts provide scale. Any company that emerges from Breakout Labs into the Founders Fund portfolio should be tracked for potential defense conversion. This mirrors the historical pattern of DARPA and [[In-Q-Tel]]: government-funded science producing commercial spinoffs. Breakout Labs inverts it: philanthropically-funded science producing companies that *then* sell to government. The directional change matters because it means the government becomes a *customer* rather than the *initiator* — changing the power relationship between technology companies and the defense establishment. ## KB Significance Breakout Labs is structurally minor (small dollar amounts, limited portfolio) but architecturally important: it completes the picture of how the Thiel network operates as a vertically-integrated system from basic research through policy influence. Understanding Breakout Labs clarifies why the network can move faster than traditional defense contractors — it controls the full pipeline from scientific discovery to government deployment. ## See Also - [[Thiel Foundation]] - [[Thiel Fellowship]] - [[Peter Thiel]] - [[Founders Fund]] - [[In-Q-Tel]] - [[Defense Tech as Asset Class]]